Phase 1 to 4
Project Portfolio, Clinical Development Path and Medical Affairs Strategy
Based on intricate understanding of the specific company and already developed data Phase 1 to 4 provides advice for project portfolio, clinical development and medical affairs strategy for the biotech, device and pharmaceutical industries.
Drugs, Medical Devices and Drug Devices
Phase 1 to 4 has experience in development as well as medical affairs support for small molecule drugs, biologics, medical devices, drug devices as well as drug delivery platforms. Phase 1 to 4 is therefore keenly aware of the idiosyncracies of each of these areas, which offers good position to avoid "blind spots" in development plans.
Execution support
Phase 1 to 4 can facilitate clients’ own execution through an extensive network with access to services ranging from protocol development, execution planning, data management, statistical analysis, regulatory reporting to publication.
Clients
IMD’s clients to date count several device, biotech and pharmaceutical companies.